Medicine: Research Notes

Two important results of wartime research were announced last week: ¶ SN 7618 is an antimalaria drug described by OSRD as "five or six times better" than atabrine. It relieves acute attacks faster and may be taken weekly, instead of daily. Unlike atabrine, it does not stain the skin or cause nausea. It costs no more to produce.

¶ Carbon-13, a rare-as-radium substance that can now be produced in quantities, may shed new light on the mysteries of human metabolism. It may also provide clues to the cause & cure of cancer, diabetes, hardening...

Want the full story?

Subscribe Now

Subscribe
Subscribe

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!